AzTrials
AzTrials

StretchNCT04871906

The Effect of Stretching Exercises on Vascular Function, Blood Flow, and Walking Function in Middle and Older Adults

A study testing stretching exercises in people with Stretch, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study examines the relationship between circulation and walking speed after performing 8-week stretching exercises. Read more about this study

Who is it for?
Ages 20 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Stretch
What is being tested?
stretching exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteTaiwan
Study dates
1 Sep 2020to 30 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age between 20-85 years old
  • Follow instructions
  • Walk with/without assistive technology

Who cannot join

  • Unstable acute or chronic health conditions
  • Peripheral vascular diseases
  • Non-musculoskeletal problems that would limit stretching exercises
  • Participate in other exercise programs

Trial locations and contacts

1 site in 1 country.

Mei-Wun Tsai, Ph.D contact

+886+2+28267939

tmwk@ym.edu.tw

Taiwan1 site, 1 recruiting
  • National Yang Ming University

    Taipei, 112

    Mei-Wun Tsai, Ph.D

    Liang-Ying Lai

    Recruiting

Other trials in Taiwan

About this study

This study examines the relationship between circulation and walking speed after performing 8-week stretching exercises.

Read the detailed description

This study examines the relationship between circulations and walking speeds. Most studies in the field of stretching exercises have only focused on improvements of endothelial functions in younger population; however, I aim to emphasize its effects on different populations, such as people with frailty, low physical activity level, weakness and postoperative status. Previous research has established that stretching exercises can improve walking function by modulations of musculoskeletal or neuromuscular system. The importance and originality of this study are that it explores the relationship between circulation and walking speed. Due to the inability to extrapolate outcomes; short-term effect of improved blood vessel function; the unclear mechanism of stretching exercises; and considering the different physical fitness groups, I design a home-based, low-dose, and anatomic chain-based stretching exercises to verify the possible mechanism and effects.

Conditions
Stretch
Being tested
stretching exercises
Keywords
stretching exercise, vascular function, blood flow, walking function, fitness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • stretching exercisesOther

    Our interventions are home-based stretching exercises. The experimental group will receive 6 stretching exercises which stretch 20-30 seconds, relax for 10 seconds, and repeat 5 times for each side. It will take 25-30 minutes every day for continuous 8 weeks. Those include stretching of the deep front line, spiral line, superficial front line, lateral line, superficial back line, and plantar flexors. Designed concepts are the following three: 1) based on ''Anatomy- Train'' theory, 2) emphasize on movements of trunk and pelvis, and 3) stress on the stretching of lower extremities.

Study groups in NCT04871906
Study groupRoleWhat they receive
Stretching exercisesExperimentalInterventions are home-based stretching exercises. The experimental group will receive 6 stretching exercises which stretch 20-30 seconds, relax for 10 seconds, and repeat 5 times for each side. It will take 25-30 minutes every day for continuous 8 weeks.
Receives: Other: stretching exercises
Control groupNo interventionMaintain their daily activity level in the 8 weeks. We use the study desigh-''waiting list control'' in this group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. vascular functions-Stiffness index(1)

    (Stiffness index, SI,unit:m/s)

    Measured: pre-intervention(1st week)

  2. vascular functions-Stiffness index(2)

    (Stiffness index, SI,unit:m/s)

    Measured: during intervention(4th week)

  3. vascular functions-Stiffness index(3)

    (Stiffness index, SI,unit:m/s)

    Measured: post-intervention(8th week)

  4. vascular functions-Reflective index(1)

    (Reflective index, RI,unit:%)

    Measured: pre-intervention(1st week)

  5. vascular functions-Reflective index(2)

    (Reflective index, RI,unit:%)

    Measured: during intervention(4th week)

  6. vascular functions-Reflective index(3)

    (Reflective index, RI,unit:%)

    Measured: post-intervention(8th week)

  7. vascular functions-Vascular age

    (Vascular age, VA,unit:year-old)

    Measured: pre-intervention(1st week)

  8. Ultrasound parameters-peak-systolic velocity(1)

    (peak-systolic velocity, PSV)

    Measured: pre-intervention(1st week)

  9. Ultrasound parameters-peak-systolic velocity(2)

    (peak-systolic velocity, PSV)

    Measured: during intervention(4th week)

  10. Ultrasound parameters-peak-systolic velocity(3)

    (peak-systolic velocity, PSV)

    Measured: post-intervention(8th week)

  11. Ultrasound parameters-end-diastolic velocity(1)

    (end-diastolic velocity, EDV)

    Measured: pre-intervention(1st week)

  12. Ultrasound parameters-end-diastolic velocity(2)

    (end-diastolic velocity, EDV)

    Measured: during intervention(4th week)

  13. Ultrasound parameters-end-diastolic velocity(3)

    (end-diastolic velocity, EDV)

    Measured: post-intervention(8th week)

  14. Ultrasound parameters-mean velocity(1)

    (mean velocity, mV)

    Measured: pre-intervention(1st week)

  15. Ultrasound parameters-mean velocity(2)

    (mean velocity, mV)

    Measured: during intervention(4th week)

  16. Ultrasound parameters-mean velocity(3)

    (mean velocity, mV)

    Measured: post-intervention(8th week)

  17. Ultrasound parameters-mean volume flow(1)

    (mean volume flow, vFl)

    Measured: pre-intervention(1st week)

  18. Ultrasound parameters-mean volume flow(2)

    (mean volume flow, vFl)

    Measured: during intervention(4th week)

  19. Ultrasound parameters-mean volume flow(3)

    (mean volume flow, vFl)

    Measured: post-intervention(8th week)

  20. Ultrasound parameters-resistance index(1)

    (resistance index, RI)

    Measured: pre-intervention(1st week)

  21. Ultrasound parameters-resistance index(2)

    (resistance index, RI)

    Measured: during intervention(4th week)

  22. Ultrasound parameters-resistance index(3)

    (resistance index, RI)

    Measured: post-intervention(8th week)

  23. Ultrasound parameters-pulsatility index(1)

    (pulsatility index, PI)

    Measured: pre-intervention(1st week)

  24. Ultrasound parameters-pulsatility index(2)

    (pulsatility index, PI)

    Measured: during intervention(4th week)

  25. Ultrasound parameters-pulsatility index(3)

    (pulsatility index, PI)

    Measured: post-intervention(8th week)

  26. Ultrasound parameters-diameter(1)

    (diameter, D)

    Measured: pre-intervention(1st week)

  27. Ultrasound parameters-diameter(2)

    (diameter, D)

    Measured: during intervention(4th week)

  28. Ultrasound parameters-diameter(3)

    (diameter, D)

    Measured: post-intervention(8th week)

  29. Ultrasound parameters-area(1)

    (area, A)

    Measured: pre-intervention(1st week)

  30. Ultrasound parameters-area(2)

    (area, A)

    Measured: during intervention(4th week)

  31. Ultrasound parameters-area(3)

    (area, A)

    Measured: post-intervention(8th week)

  32. walking speed-preferred(1)

    Timed 10-Meter Walk Test (preferred)

    Measured: pre-intervention(1st week)

  33. walking speed-preferred(2)

    Timed 10-Meter Walk Test (preferred)

    Measured: during intervention(4th week)

  34. walking speed-preferred(3)

    Timed 10-Meter Walk Test (preferred)

    Measured: post-intervention(8th week)

  35. walking speed-fast(1)

    Timed 10-Meter Walk Test (fast)

    Measured: pre-intervention(1st week)

  36. walking speed-fast(2)

    Timed 10-Meter Walk Test (fast)

    Measured: during intervention(4th week)

  37. walking speed-fast(3)

    Timed 10-Meter Walk Test (fast)

    Measured: post-intervention(8th week)

Secondary outcomes (20)
  1. body composition-height

    height(cm)

    Measured: pre-intervention(1st week)

  2. body composition-weight

    weight(kg)

    Measured: pre-intervention(1st week)

  3. body composition-waist circumference

    waist circumference(cm)

    Measured: pre-intervention(1st week)

  4. vital sign-blood pressure(1)

    blood pressure(mmHg)

    Measured: pre-intervention(1st week)

  5. vital sign-blood pressure(2)

    blood pressure(mmHg)

    Measured: during intervention(4th week)

  6. vital sign-blood pressure(3)

    blood pressure(mmHg)

    Measured: post-intervention(8th week)

  7. vital sign-heart rate(1)

    heart rate(bpm)

    Measured: pre-intervention(1st week)

  8. vital sign-heart rate(2)

    heart rate(bpm)

    Measured: during intervention(4th week)

  9. vital sign-heart rate(3)

    heart rate(bpm)

    Measured: post-intervention(8th week)

  10. flexibility-chair sit and reach test (1)

    chair sit and reach test (cm)

    Measured: pre-intervention(1st week)

  11. flexibility-chair sit and reach test (2)

    chair sit and reach test (cm)

    Measured: during intervention(4th week)

  12. flexibility-chair sit and reach test (3)

    chair sit and reach test (cm)

    Measured: post-intervention(8th week)

  13. grip strength

    hand dynamometer

    Measured: pre-intervention(1st week)

  14. cognitive function

    Montreal Cognitive Assessment.Minimum value is 0 and maximum value is 30, and higher scores mean a better outcome

    Measured: pre-intervention(1st week)

  15. frailty

    SOF (Study of Osteoporotic Fractures). Minimum value is 0 and maximum value is 3, and higher scores mean a worse outcome

    Measured: pre-intervention(1st week)

  16. basic data

    gender, age, education, living status, smoking, and exercise habits

    Measured: pre-intervention(1st week)

  17. ACSM-PAR-Q+

    The Physical Activity Readiness Questionnaire for Everyone AND follow-up questions about their medical conditions (PAR-Q+) is used to identify whether subjects are at risk in engaging in exercises. Thus, researchers can prescribe individual exercise prescriptions.

    Measured: pre-intervention(1st week)

  18. IPAQ

    International Physical Activity Questionnaire to investigate their physical activity levels. Higher the amount of physical activity (min-METs/week) means a more active life-style(physical activity level).

    Measured: pre-intervention(1st week)

  19. fitness

    (Duke activity status index, DASI) Minimum value is 0 and maximum value is 58.2, and higher scores mean a better physical activity level.

    Measured: pre-intervention(1st week)

  20. adherence of exercise

    usage records from the Line app

    Measured: post-intervention(8th week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2021
  2. Study start1 Sep 2020
  3. Primary completion30 Jun 2021 (estimated)
  4. Study completion30 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04871906
Sponsor's protocol ID
YM109100E
Status last verified
Apr 2021
First submitted
26 Apr 2021
Last updated
4 May 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing stretching exercises in people with Stretch, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mei-Wun Tsai, Ph.D (+886+2+28267939, tmwk@ym.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

vascular functions-Stiffness index(1) (time frame: pre-intervention(1st week)). The study lists 37 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in